Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Mar 31 2014
In response to the Environmental Protection Agency’s (EPA) announcement it will halt new petitions for renewable fuel pathways for approximately six...
Mar 27 2014
Washington, D.C. (March 27, 2014) – The Biotechnology Industry Organization (BIO), the National Science Foundation (NSF) and the National Institutes...
Mar 27 2014
Washington, DC – Thursday, March 27, 2014 – Today, the Biotechnology Industry Organization (BIO) announced that Kay Holcombe will be joining...
Mar 26 2014
If left unchanged, the Obama administration’s proposal to slash use of biofuels in 2014 would increase emissions of greenhouse gases next year,...
Mar 25 2014
The following is an update from a previous version.   Washington, D.C. (March 26, 2014) – The Biotechnology Industry Organization (BIO) and the...
Mar 25 2014
Nobel Laureate and Father of “Green Revolution” Honored in the National Statuary Hall WASHINGTON, D.C. (March 25, 2014) – On what would...
Mar 25 2014
Washington, D.C. (March 25, 2014) – The Biotechnology Industry Organization (BIO) today reaffirmed and broadened its long-standing commitment to...
Mar 24 2014
BIO announces speakers at 2014 World Congress in Philadelphia   Washington, D.C. (March 24, 2014) – Advanced biofuel producers will discuss...
Mar 24 2014
Washington, DC (March 24, 2014) – David Brancaccio, host of American Public Media’s Marketplace Morning Report, will deliver opening remarks at...


Biotechnology News

September 2, 2014

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex to Present for the First Time at the 32nd Annual World Congress of Endourology and Shockwave Lithotripsy

September 2, 2014

NEW YORK--(BUSINESS WIRE)--David R. Guyer, M.D., CEO of Ophthotech Corp. will present an overview of the Company at the Morgan Stanley Global Healthcare Conference in New...

September 2, 2014

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical Inc. announces the closing of a $16 million Series B financing to fund continued development of its proprietary...

September 2, 2014

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company’s fiscal...

September 2, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that Ron Cohen, M.D., President and Chief Executive Officer, and Andrew A. Hindman...